L. Sieverding et al., PROTON-DECOUPLED MYOCARDIAL P-31 NMR-SPECTROSCOPY REVEALS DECREASED PCR P-I IN PATIENTS WITH SEVERE HYPERTROPHIC CARDIOMYOPATHY/, The American journal of cardiology, 80(3A), 1997, pp. 34-40
Disturbed myocardial energy metabolism may occur in patients with prim
ary hypertrophic cardiomyopathy (HCM). A noninvasive way to gain insig
ht into cardiac energy metabolism is provided by in vivo P-31 nuclear
magnetic resonance (NMR) spectroscopy. P-31 NMR spectroscopy with prot
on decoupling was performed in 13 patients aged 13-36 years with HCM o
n a 1.5 T Magnetom with a double resonant surface coil. A 2D chemical
shift imaging (CSI) sequence in combination with slice selective excit
ation was used to acquire spectra of the anteroseptal region of the le
ft ventricle (volume element: 38 mL). The chemical shifts of the phosp
horus metabolites, intracellular pH(i), and coupling constants J(alpha
beta) and J(gamma beta) were calculated, Peak areas of 2,3-diphosphog
lycerate (DPG), P-i, and adenosine triphosphate (ATP) were determined
and corrected for blood contamination, saturation, and differences in
nuclear Overhauser enhancements (NOE). The maximum thickness of the in
terventricular septum (IVSmax) was determined from tomographic long-ax
is images and expressed as number of standard deviations above the mea
n of the normal population (Z score). The patients were then divided i
nto 2 groups: 6 patients with moderate HCM (HCMm, Z score less than or
equal to 5) and 7 patients with severe HCM (HCMs, Z score > 5). No di
fferences between both groups and a control group of healthy volunteer
s (n = 16) were found with respect to phosphocreatine (PCr)/gamma-ATP
ratio, pH(i), or the coupling constants. Only the PCr/P-i ratio differ
ed significantly from the control group (HCMall, alpha < 0.05, HCMs, a
lpha < 0.02, 2-sided U test). The decrease of the PCr/Pi ratio in pati
ents with HCM is probably caused by ischemically decreased oxygen supp
ly in the severely hypertrophied myocardium. (C) 1997 by Excerpta Medi
ca, Inc.